Wensi Zhao

Fecal microbiota transplantation plus tislelizumab and fruquintinib in refractory microsatellite stable metastatic colorectal cancer: an open-label, single-arm, phase II trial (RENMIN-215)

Wensi Zhao, Jun Lei, Shaobo Ke et al. · EClinicalMedicine · 2023 · 116 citations · Full text

Medicine, Immunology, Oncology +14

Comparative evaluation of label-free quantification strategies

Lei Zhao, Xiaoji Cong, Linhui Zhai et al. · Journal of Proteomics · 2020 · 74 citations

Language Studies, Mathematics, Computational Linguistics +11

Radiotherapy plus camrelizumab and irinotecan for oligometastatic esophageal squamous cell carcinoma patients after first-line immunotherapy plus chemotherapy failure: An open-label, single-arm, phase II trial

Wensi Zhao, Shaobo Ke, Xiaojun Cai et al. · Radiotherapy and Oncology · 2023 · 40 citations

Medicine, Oncology, Pharmacotherapy +16

Integrative multi-omics and drug–response characterization of patient-derived prostate cancer primary cells

Ziruoyu Wang, Yanan Li, Wensi Zhao et al. · Signal Transduction and Targeted Therapy · 2023 · 35 citations · Full text

Medicine, Oncology, Pharmacology +17

Genome-scale CRISPR activation screening identifies a role of ELAVL2-CDKN1A axis in paclitaxel resistance in esophageal squamous cell carcinoma.

Wensi Zhao, Wanpu Yan, Dongbo Chen et al. · PubMed · 2019 · 31 citations · Full text

Medicine, Molecular Biology, Oncology +17